News About: Pharm. Industry
Aloe becomes less popular in Korea
Aloe has become less attractive to Korean people, with other functional foods, such as red ginseng and omega products, getting their momentum.
According to the Korea Food and Drug Administration, the domestic aloe ...
Major firms forecast to suffer poor Q1 results
Seven major pharmaceutical companies are likely to see their first-quarter earnings worsen with operating and net profits falling 40 percent and 34 percent, respectively buffeted by stubbornly weak domestic demand, ac...
AstraZeneca Korea will move to new headquarters
AstraZeneca Korea, a Korean unit of AstraZeneca, the world's sixth-largest pharmaceutical company, will move Wednesday from its office to a new seventeen-story building in Songpa-ku, Seoul.
“Now all of our employe...
Drug makers gather to tackle drug price cut
Members of the Korea Pharmaceutical Manufacturers Association (KPMA) gathered to discuss the government’s policy to sharply lower all drug prices, aiming to stabilize the nation's health insurance finance suffering fr...
Government calls for RCT data over 41 therapeutic categories
Manufactures of drugs that belong to 41 therapeutic categories will have to submit the randomized controlled clinical trial (RCT) data to the Health Insurance Review and Assessment Service until May 16, as the HIRA wi...
Wholesalers protest against Takeda’s low margin policy
Domestic wholesalers have recently protested against Takeda Pharma Korea, demanding it provide a 12-percent wholesaler margin as given before by CJ Cheiljedang.
The move came when Takeda reduced the wholesaler marg...
Non-listed drugmakers reluctant to spend on R&D
Non-listed Korean manufacturers that chalked up sales of over hundred billion won last year, invested less than 1 percent of their revenue in research.
Yakup Shinmoon said recently that three out of 31 firms with a...
Bacchus, bestselling product
Dong-A Pharmaceutical’s Bacchus drink turned out as Korea's best-selling drug product last year, industry data showed recently.
Bacchus, a tonic product, sold 128.2 billion won's worth last year, according to data ...
79 drugmakers spend 321.7 billion won of revenue on promotion in 2010
A total of 79 Korean drug manufacturers spent 321.7 billion won to promote their products last year, showing a 10-percent decrease compared with 358.6 billion won from a year earlier, according to data released by Yak...
Chong Kun Dang opens R&D center
Chong Kun Dang Pharmaceutical said Wednesday it has opened Hyojong research & development (R&D) center in Yongin City, Kyunggi Province.
Hyojong stands for a dawn-breaking bell, reflecting the company’ motto to dev...
